Olivier Terrier
Olivier Terrier
VirPath Team, Centre international de Recherche en Infectiologie (CIRI), INSERM U1111 UMR CNRS 5308
Verified email at
Cited by
Cited by
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
P Maisonnasse, J Guedj, V Contreras, S Behillil, C Solas, R Marlin, ...
Nature 585 (7826), 584-587, 2020
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia
A Pizzorno, B Padey, T Julien, S Trouillet-Assant, A Traversier, ...
Cell Reports Medicine 1 (4), 2020
Timing of antiviral treatment initiation is critical to reduce SARS‐CoV‐2 viral load
A Gonçalves, J Bertrand, R Ke, E Comets, X De Lamballerie, D Malvy, ...
CPT: pharmacometrics & systems pharmacology 9 (9), 509-514, 2020
Influenza viruses and mRNA splicing: doing more with less
J Dubois, O Terrier, M Rosa-Calatrava
MBio 5 (3), 10.1128/mbio. 00070-14, 2014
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
A Pizzorno, B Padey, J Dubois, T Julien, A Traversier, V Dulière, P Brun, ...
Antiviral research 181, 104878, 2020
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses
B Essere, M Yver, C Gavazzi, O Terrier, C Isel, E Fournier, F Giroux, ...
Proceedings of the National Academy of Sciences 110 (40), E3840-E3848, 2013
Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3
D Thuringer, G Jego, G Wettstein, O Terrier, L Cronier, N Yousfi, ...
The FASEB Journal 27 (10), 4169-4183, 2013
Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy
A Pizzorno, B Padey, O Terrier, M Rosa-Calatrava
Frontiers in immunology 10, 435562, 2019
Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response
V Marcel, K Fernandes, O Terrier, DP Lane, JC Bourdon
Cell Death & Differentiation 21 (9), 1377-1387, 2014
Cold oxygen plasma technology efficiency against different airborne respiratory viruses
O Terrier, B Essere, M Yver, M Barthélémy, M Bouscambert-Duchamp, ...
Journal of Clinical Virology 45 (2), 119-124, 2009
Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a
O Terrier, J Textoris, C Carron, V Marcel, JC Bourdon, M Rosa-Calatrava
Journal of General Virology 94 (5), 985-995, 2013
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Infection 49 (5), 889-905, 2021
Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release
S Eymieux, Y Rouillé, O Terrier, K Seron, E Blanchard, M Rosa-Calatrava, ...
Cellular and Molecular Life Sciences 78, 3565-3576, 2021
The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses
F Durupt, D Koppers-Lalic, B Balme, L Budel, O Terrier, B Lina, L Thomas, ...
Cancer gene therapy 19 (1), 58-68, 2012
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
D Asarnow, B Wang, WH Lee, Y Hu, CW Huang, B Faust, PML Ng, ...
Cell 184 (12), 3192-3204. e16, 2021
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
Q Le Hingrat, B Visseaux, C Laouenan, S Tubiana, L Bouadma, ...
Clinical Microbiology and Infection 27 (5), 789. e1-789. e5, 2021
Viral and bacterial co-infection in severe pneumonia triggers innate immune responses and specifically enhances IP-10: a translational study
J Hoffmann, D Machado, O Terrier, S Pouzol, M Messaoudi, W Basualdo, ...
Scientific reports 6 (1), 38532, 2016
The system can't perform the operation now. Try again later.
Articles 1–20